A Study Evaluating The Safety, Tolerability, Pharmacokinetics, And Efficacy Of Venetoclax In Combination With Atezolizumab, Carboplatin, And Etoposide In Participants With Untreated Extensive-Stage Small Cell Lung Cancer (ES-SCLC).
Clinical trial NCT04422210 · TERMINATED
Trial details
- NCT number
- NCT04422210
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-22
- Primary completion
- 2020-11-06
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.